Topic: How To Invest

Wall Street Stock Forecaster Hotline – Friday, April 1, 2022

Article Excerpt

PFIZER INC., $51.57, New York symbol PFE, is your #1 Income Buy for 2022. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia). Pfizer has increased its dividend rate each year since 2011. Starting with the March 2022 payment, the company raised your quarterly dividend by 2.6%. Investors now receive $0.40 a share instead of $0.39. The new annual rate of $1.60 yields a solid 3.1%. This week, the U.S. Food and Drug Administration approved a second booster shot of Pfizer’s COVID-19 vaccine (called Comirnaty) for adults over 50 years of age and those with compromised immune systems. That would help protect people from the new, more contagious BA.2 version of the Omicron variant. Initially, individuals received two shots of the vaccine. Due to the emergence of new variants, the FDA approved a first booster shot in late 2021. Individuals must wait four months before receiving their second booster. Pfizer…